Impact Biomedical IBO
NYSE IBO
$3.60 -0.20 (-5.26%)
At close: Oct 23, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Long-Term Debt Repayments (2026)

Updated

Impact Biomedical (IBO) posted Long-Term Debt Repayments of $1,000 for Q1 2026.

Analysis

Impact Biomedical (IBO) Long-Term Debt Repayments (2026) Analysis & Trends

For FY2025, Impact Biomedical's Long-Term Debt Repayments came in at $293,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 1.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 2.00 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Impact Biomedical 388.16 Mn 391.36 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
API Access

Impact Biomedical Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=IBO&period=max&api_key=YOUR_API_KEY